Andrew Ashe
2022
In 2022, Andrew Ashe earned a total compensation of $3.3M as President, Chief Operating Officer and General Counsel at Verve Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $215,280 |
|---|---|
| Option Awards | $2,615,650 |
| Salary | $476,100 |
| Other | $12,468 |
| Total | $3,319,498 |
Ashe received $2.6M in option awards, accounting for 79% of the total pay in 2022.
Ashe also received $215.3K in non-equity incentive plan, $476.1K in salary and $12.5K in other compensation.
Rankings
In 2022, Andrew Ashe's compensation ranked 1,082nd out of 5,542 executives tracked by ExecPay. In other words, Ashe earned more than 80.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,082 out of 5,542 | 81st |
Division Manufacturing | 512 out of 3,000 | 83rd |
Major group Chemicals And Allied Products | 183 out of 1,350 | 86th |
Industry group Drugs | 164 out of 1,253 | 87th |
Industry Pharmaceutical Preparations | 123 out of 907 | 86th |
Source: SEC filing on April 28, 2023.
Ashe's colleagues
We found two more compensation records of executives who worked with Andrew Ashe at Verve Therapeutics in 2022.